Frankfurt
31.10.25 | 08:06
0,056 Euro
+6,73 % +0,004
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,053 | 0,077 | 02.11. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Ventripoint Diagnostics Ltd (2): Ventripoint to test AI-enhanced echocardiography | 1 | Stockwatch | ||
| Mi | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics and Providence Health Care Ventures Announce Collaboration to Validate AI-Enabled Cardiac Imaging at St. Paul's Hospital | 1 | TheNewswire | ||
| 24.10. | Ventripoint Diagnostics Ltd (2): Ventripoint talks VMS+, sales expansion, partnerships | 2 | Stockwatch | ||
| 24.10. | Ventripoint Diagnostics Ltd.: Ventripoint Provides Corporate Update and Announces Shareholder Teleconference | 1 | TheNewswire | ||
| 14.10. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Closing of Second and Final Tranche of Non-Brokered Convertible Debenture Units Private Placement | 1 | TheNewswire | ||
| VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 03.10. | Ventripoint Diagnostics Ltd (2): Ventripoint to extend, increase debenture financing | 2 | Stockwatch | ||
| 03.10. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Extension and Up Size of Non-Brokered Convertible Debenture Unit Private Placement | 2 | TheNewswire | ||
| 19.09. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics completes annual quality audit | 1 | Stockwatch | ||
| 19.09. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Successful Completion of Key Quality Audits | 2 | TheNewswire | ||
| 03.09. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Closing of First Tranche of Non-Brokered Convertible Debenture Unit Private Placement | 1 | TheNewswire | ||
| 27.08. | Ventripoint Diagnostics Ltd (2): Ventripoint arranges $5M financing of debenture units | 1 | Stockwatch | ||
| 26.08. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Non-Brokered Convertible Debenture Units Private Placement and Share Issuance | 2 | TheNewswire | ||
| 19.08. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Brown as program director | 1 | Stockwatch | ||
| 18.08. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Appoints Thomas Brown as Director of Congenital Heart Defect Program | 1 | TheNewswire | ||
| 15.08. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Launches Targeted Congenital Heart Defect Marketing Program, Setting Stage for Multi-Segment Growth | 1 | TheNewswire | ||
| 13.08. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Cardiac MRI Alternative Gets FDA Nod - Ventripoint CEO on U.S. and China Sales Plans | 332 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 13, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining... ► Artikel lesen | |
| 29.07. | Ventripoint Diagnostics Ltd (2): Ventripoint receives purchase order from Lishman | 1 | Stockwatch | ||
| 28.07. | Ventripoint Diagnostics Ltd.: Lishman Global Places First Order for Ventripoint's VMS+ Technology | 1 | TheNewswire | ||
| 11.07. | Ventripoint Diagnostics Ltd (2): Ventripoint enters term sheet with Lishman for licence | 1 | Stockwatch | ||
| 11.07. | Ventripoint Diagnostics Ltd.: Ventripoint and Lishman Global Sign Non-binding Term Sheet Defining License for VMS+ Technology | 2 | TheNewswire |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 0,786 | +1,68 % | Atossa Therapeutics Inc: Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness | 25+ year life-sciences finance leader brings revenue-forecasting rigor, public-company controls, and capital-markets experience as Atossa prepares for commercial... ► Artikel lesen | |
| TANDEM DIABETES | 11,975 | -1,40 % | Tandem Diabetes To Pay Roche $36 Mln To Settle Patent Infringement Claim | SOUTH SAN FRANCISCO (dpa-AFX) - Tandem Diabetes Care, Inc. has agreed to pay Roche Holding $36 million over a five year period to settle a patent infringement claim.On May 21, Tandem Diabetes... ► Artikel lesen | |
| VERU | 2,990 | -0,33 % | Veru Inc.: Veru to Present Two Abstracts at ObesityWeek 2025 | ||
| MOLINA HEALTHCARE | 133,00 | +0,19 % | Nächstes Beben: Molina Healthcare crasht - UnitedHealth schwach | Die US-Krankenversicherer kommen nicht zur Ruhe. Am Mittwochabend hat der Gesundheitsdienstleister Molina Healthcare die Anleger mit enttäuschenden Zahlen erneut verunsichert. Die Aktie brach daraufhin... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,100 | +1,47 % | Clover Health Investments, Corp.: Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service | WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company") today announced that Chelsea Clinton, the longest-serving... ► Artikel lesen | |
| COGNETIVITY NEUROSCIENCES | 0,015 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 02.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.06.2025ISIN NameCA19243C1005 COGNETIVITY... ► Artikel lesen | |
| SEMLER SCIENTIFIC | 23,200 | +1,75 % | Strive, Inc. (Nasdaq: ASST) and Semler Scientific, Inc. (Nasdaq: SMLR) Announce Bitcoin Treasury Merger in All-Stock Transaction | DALLAS, TX and CAMPBELL, CA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. ("Strive") entered into a definitive agreement to acquire Semler Scientific, Inc. ("Semler Scientific") in an all-stock... ► Artikel lesen | |
| SOMNIGROUP INTERNATIONAL | 69,50 | +0,72 % | If You Invested $1000 In Somnigroup International Stock 5 Years Ago, You Would Have This Much Today | ||
| SHL TELEMEDICINE | - | - | SHL TELEMEDICINE LTD - 6-K, Report of foreign issuer | ||
| SINTX TECHNOLOGIES | 3,210 | -6,96 % | SiNtx Technologies, Inc.: SINTX Technologies erhält FDA-Zulassung für SINAPTIC Fuß- und Sprunggelenk-Implantatsystem | Das von der FDA zugelassene und in den USA hergestellte Implantatsystem positioniert SINTX für den Eintritt in den milliardenschweren US-Markt
SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| SMILEDIRECTCLUB | - | - | Align Technology Settles Antitrust Lawsuit Over SmileDirectClub Deal for $31.75 Million | ||
| NEURONETICS | 2,370 | +2,38 % | Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence | MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of... ► Artikel lesen | |
| FRESENIUS | 50,02 | -0,68 % | DEUTSCHE BANK RESEARCH stuft Fresenius SE auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Fresenius von 52 auf 53 Euro angehoben und die Einstufung auf "Buy" belassen. Die anstehenden Quartalszahlen des Medizinkonzerns... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 46,560 | -0,11 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,570 | -0,31 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |
VENTRIPOINT DIAGNOSTICS LTD gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,056 Euro und damit +6,73 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENTRIPOINT DIAGNOSTICS LTD finden Sie auf Wallstreet Online.